Skip to content
healthcare.dev

Guaifenesin Extended-Release

NDC 68094-048, Guaifenesin, tablet, multilayer, extended release, from Precision Dose Inc..

Product NDC
68094-048
Status
Listed
Labeler
Precision Dose Inc.
Dosage form
TABLET, MULTILAYER, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA078912
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68094-048 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN600 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
68094-048-616809400486110 BLISTER PACK in 1 CARTON (68094-048-61) / 10 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK (68094-048-59)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 68094004861

    GET /v1/drugs/nadac/68094004861

Use it

Look up 68094-048 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68094-048 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68094-048. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.